Biotech Innovation Shift: In the global prestige anti-aging and clinical regenerative market, traditional animal-derived collagens (bovine and porcine) are being rapidly phased out. Brand founders and aesthetic clinics now demand biocompatible, pathogen-free bio-fermentation: 100% Human-Homologous Recombinant Type-III Collagen featuring an intact 164.88° flexible triple-helix architecture.
For decades, anti-aging moisturizers and serums relied on hydrolyzed animal collagen. However, animal-extracted proteins present fundamental physiological limitations when formulated for clinical skincare:
Allergenicity & Immune Rejection: Animal telopeptides carry inherent foreign-protein immunogenicity, frequently triggering micro-inflammatory flare-ups on sensitive or post-treatment skin barriers.
Denatured Inactive Scaffolding: Harsh chemical and enzymatic extraction destroys the natural triple-helix conformation, reducing the ingredient to a simple inert humectant rather than an active signaling scaffold.
Viral & Pathogen Transmission Risks: Zoonotic contamination risks prevent animal collagen from meeting modern clean-label and pharmaceutical cleanroom standards.
Figure 1: Dermatological evaluation verified by Intertek: 0% skin irritation rate, -35% dynamic wrinkle count, and +19% elasticity support after 28 days.
Extracted from bovine/porcine tissues with risk of zoonotic pathogens.
Fragmented single-chain structure lacks mechanical ECM tensile support.
Potential immunogenicity and rejection in fragile barrier types.
100% Human Homology: Zero rejection, verified 0.00% irritation rate.
Patented 164.88° flexible triple-helix structure restores dermal elasticity.
Bio-fermented animal-free synthesis meets EU/US clean-label requirements.
While Type-I collagen provides coarse structural toughness, Type-III collagen is often known as "baby collagen"—providing elasticity, delicate skin bounce, and tissue repair signaling. As skin ages, the ratio of Type-III collagen plummets from 80% in infants to below 15% in mature adults.
Figure 2: Microscopic illustration of the 164.88° triple-helix collagen scaffold anchoring into native dermal matrices alongside bio-peptide SNARE relaxation.
Unlike flat peptides, the 164.88° helix spatial angle preserves the biological binding motifs that directly integrate into native fibroblast niches. It provides structural scaffolding, filling hollow micro-creases and promoting self-collagen production.
Working synergistically with recombinant proteins, neuromuscular bio-peptides relax repeated facial micro-contractions, preventing structural collagen fibers from breaking along high-stress expression zones (forehead and periocular areas).
High-viscosity Tremella polysaccharides and micro-molecular hyaluronic acid form a breathable moisture reservoir on the stratum corneum, locking active recombinant proteins within dermal absorption channels.
Figure 3: Multi-tier active ingredients architecture engineered for clinical ECM rebuilding and moisture retention.
Clinical serums require packaging that communicates biotechnological prestige. Our turnkey private label configurations offer seamless commercialization options:
Figure 4: 30ml luxury amber dropper bottle with rigid presentation box engineered for aesthetic clinics and premium DTC retail.
| Specification Matrix | Clinical Discovery / Ad Tier | Prestige Clinic Flagship Line |
|---|---|---|
| Packaging Option | 10ml Deluxe Amber Precision Dropper Vial | 30ml Luxury Dropper Serum Bottle in Rigid Box |
| Distribution Channel | Low CAC ad campaigns, VIP travel kits, salon trial kits | Aesthetic clinics, dermatology centers, luxury DTC hero SKU |
| Target MSRP Positioning | $22 – $35 (Trial Kit) | $75 – $130 (Retail Full Size) |
| Cross-Category Protocol | Formulated to follow acute cellular recovery in our PDRN Post-Procedure Recovery Protocol, and sealed in with our 30% Pro-Xylane & Peptide Barrier Recovery Cream. | |
Formulating sensitive bio-fermented proteins requires absolute environmental hygiene. Shanghai Viansh Wellness Technology offers full pharmaceutical-grade contract manufacturing:
Aseptic Processing: Class 100,000 sterile cleanroom facility certified under ISO 22716 & GMPC.
Full Global Dossiers: US FDA MoCRA registered, accompanied by comprehensive MSDS, third-party SGS/Intertek efficacy testing, and COA documentation.
Agile Prototyping: Rapid 3–5 day custom lab sample dispatch; low minimum order quantities starting from 3,000 units.
Whether you are launching a flagship 30ml clinical anti-wrinkle serum or scaling lead generation with high-converting trial sets, our R&D specialists are ready to collaborate.
Intimate Gel Tech & Mucosal Repair
Intimate Gel Tech & Mucosal Repair
Microbiome Wash & Freshness Mists
October 09,2026
October 06,2026
September 28,2026Disclaimer: Our products are topical skincare and personal care formulations. They are not intended to diagnose, treat, cure, or prevent any medical condition. Copyright © 2026 Shanghai Viansh Wellness Technology Co., Ltd. All Rights Reserved.